The involvement of the complement pathway, specifically the release of anaphylatoxins C3a and C5a through cleavage of C3 and C5 (26), as well as the coagulation cascade contributing to intravascular coagulation in the lung (27), has been implicated in the mechanism of COVID-19. This evidence concerns the gene C3 and COVID-19.